AUTL
Price
$1.27
Change
-$0.02 (-1.55%)
Updated
Nov 19 closing price
Capitalization
338M
110 days until earnings call
Intraday BUY SELL Signals
IPSC
Price
$0.52
Change
+$0.03 (+6.12%)
Updated
Nov 19 closing price
Capitalization
44.84M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUTL vs IPSC

Header iconAUTL vs IPSC Comparison
Open Charts AUTL vs IPSCBanner chart's image
Autolus Therapeutics
Price$1.27
Change-$0.02 (-1.55%)
Volume$1.47M
Capitalization338M
Century Therapeutics
Price$0.52
Change+$0.03 (+6.12%)
Volume$885.74K
Capitalization44.84M
AUTL vs IPSC Comparison Chart in %
AUTL
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUTL vs. IPSC commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (AUTL: $1.27 vs. IPSC: $0.51)
Brand notoriety: AUTL and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 47% vs. IPSC: 85%
Market capitalization -- AUTL: $338M vs. IPSC: $44.84M
AUTL [@Biotechnology] is valued at $338M. IPSC’s [@Biotechnology] market capitalization is $44.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • AUTL’s TA Score: 3 bullish, 6 bearish.
  • IPSC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than AUTL.

Price Growth

AUTL (@Biotechnology) experienced а -6.62% price change this week, while IPSC (@Biotechnology) price change was -8.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

AUTL is expected to report earnings on Mar 10, 2026.

IPSC is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($338M) has a higher market cap than IPSC($44.8M). AUTL YTD gains are higher at: -45.957 vs. IPSC (-49.149). IPSC has higher annual earnings (EBITDA): -6.16M vs. AUTL (-232.19M). AUTL has more cash in the bank: 454M vs. IPSC (156M). IPSC has less debt than AUTL: IPSC (51.5M) vs AUTL (64.5M). IPSC has higher revenues than AUTL: IPSC (114M) vs AUTL (29.9M).
AUTLIPSCAUTL / IPSC
Capitalization338M44.8M754%
EBITDA-232.19M-6.16M3,771%
Gain YTD-45.957-49.14994%
P/E RatioN/AN/A-
Revenue29.9M114M26%
Total Cash454M156M291%
Total Debt64.5M51.5M125%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLIPSC
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COOSF10.060.48
+5.06%
Carbios SA
BACHY14.950.03
+0.23%
Bank of China, Ltd.
IDKOF6.76N/A
N/A
Idemitsu Kosan Co., Ltd.
SMDZF0.16N/A
N/A
Strategic Metals Ltd. New
SZGPF33.54N/A
N/A
Salzgitter AG

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-1.55%
OCUL - AUTL
47%
Loosely correlated
+2.81%
IMTX - AUTL
46%
Loosely correlated
N/A
CRSP - AUTL
45%
Loosely correlated
-5.12%
NRIX - AUTL
45%
Loosely correlated
+13.09%
IPSC - AUTL
43%
Loosely correlated
+4.82%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with IMNM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+4.82%
IMNM - IPSC
54%
Loosely correlated
-1.06%
CRSP - IPSC
51%
Loosely correlated
-5.12%
RXRX - IPSC
49%
Loosely correlated
-3.12%
ARWR - IPSC
49%
Loosely correlated
-3.71%
FATE - IPSC
48%
Loosely correlated
+2.94%
More